Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02996032 · ClinicalTrials.gov registry record
CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 187
- Enrollment target
NCT02996032 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 187 participants.
The verdict
NCT02996032 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 187 participants
- Enrollment target
Study Summary
This is a study to determine if two ultrasound measures (Corrected Flow Time and B-Lines) can predict patients at higher risk of readmission within 30 days of hospital discharge for decompensated heart failure.
Interventions
- OTHER Vascular and Pulmonary Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02996032
The ClinicalTrials.gov registry entry for NCT02996032 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vascular and Pulmonary Ultrasound is the first listed.
NCT02996032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02996032 about?
NCT02996032 is a clinical study titled "CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study". This is a study to determine if two ultrasound measures (Corrected Flow Time and B-Lines) can predict patients at higher risk of readmission within 30 days of hospital discharge for decompensated heart failure.
What is the current status of trial NCT02996032?
This trial is currently completed. The enrollment target is 187 participants. The study started on 2016-11. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02996032?
The interventions under investigation include: Vascular and Pulmonary Ultrasound (OTHER).
Who is sponsoring clinical trial NCT02996032?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.